Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

Updated June 23rd, 2020

Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

NOW
PLAYING
Using CAR T-Cell Therapy Earlier
NOW
PLAYING
CAR T-Cell Therapy's Current and Future Success
NOW
PLAYING
CRS: A CAR T-cell therapy side effect
NOW
PLAYING
If You're Over 65, Here's What You Need to Know About CAR T-Cell Therapy
NOW
PLAYING
Drawing Blood for CAR T-Cell Therapy
NOW
PLAYING
CAR T-Cell Therapy: A Step-By-Step Guide to Having This Breakthrough Treatment

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.